HK1222357A1 - 胰島素管理 - Google Patents

胰島素管理

Info

Publication number
HK1222357A1
HK1222357A1 HK16110587.0A HK16110587A HK1222357A1 HK 1222357 A1 HK1222357 A1 HK 1222357A1 HK 16110587 A HK16110587 A HK 16110587A HK 1222357 A1 HK1222357 A1 HK 1222357A1
Authority
HK
Hong Kong
Prior art keywords
insulin management
insulin
management
Prior art date
Application number
HK16110587.0A
Other languages
English (en)
Inventor
Robert C Booth
Harry Hebblewhite
Original Assignee
Aseko Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aseko Inc filed Critical Aseko Inc
Publication of HK1222357A1 publication Critical patent/HK1222357A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14288—Infusion or injection simulation
    • A61M2005/14296—Pharmacokinetic models
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/18—General characteristics of the apparatus with alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3561—Range local, e.g. within room or hospital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3569—Range sublocal, e.g. between console and disposable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
HK16110587.0A 2014-01-31 2016-09-06 胰島素管理 HK1222357A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461934300P 2014-01-31 2014-01-31
US14/511,060 US9486580B2 (en) 2014-01-31 2014-10-09 Insulin management
PCT/US2015/011086 WO2015116371A1 (en) 2014-01-31 2015-01-13 Insulin management

Publications (1)

Publication Number Publication Date
HK1222357A1 true HK1222357A1 (zh) 2017-06-30

Family

ID=53753955

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16110587.0A HK1222357A1 (zh) 2014-01-31 2016-09-06 胰島素管理

Country Status (8)

Country Link
US (8) US9486580B2 (zh)
EP (2) EP3046599B1 (zh)
JP (2) JP6602784B2 (zh)
AU (1) AU2015211352B2 (zh)
CA (1) CA2926761C (zh)
HK (1) HK1222357A1 (zh)
IL (1) IL246936A (zh)
WO (1) WO2015116371A1 (zh)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
CA2816314C (en) 2010-10-31 2018-03-06 Trustees Of Boston University Blood glucose control system
TW201333870A (zh) 2011-12-21 2013-08-16 艾登工具股份有限公司 決定病人胰島素療法的系統及方法
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
US9486580B2 (en) * 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
CN106456064B (zh) 2014-01-31 2020-11-27 波士顿大学董事会 基于在前时期的离线葡萄糖控制
US9792373B2 (en) * 2014-12-31 2017-10-17 Facebook, Inc. Systems and methods to determine trending topics for a user based on social graph data
EP4400130A3 (en) 2015-02-18 2024-10-16 Insulet Corporation Fluid delivery and infusion devices
WO2017027459A1 (en) 2015-08-07 2017-02-16 Trustees Of Boston University Glucose control system with automatic adaptation of glucose target
EP3337402A4 (en) * 2015-08-20 2019-04-24 Aseko, Inc. THERAPY ADVISER FOR THE MANAGEMENT OF DIABETES
EP3374905A1 (en) 2016-01-13 2018-09-19 Bigfoot Biomedical, Inc. User interface for diabetes management system
WO2017123703A2 (en) 2016-01-14 2017-07-20 Bigfoot Biomedical, Inc. Occlusion resolution in medication delivery devices, systems, and methods
EP3443998A1 (en) 2016-01-14 2019-02-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US20170263156A1 (en) * 2016-03-08 2017-09-14 Quattro Folia Oy Method and system for recommending a set of insulin dosages for a patient
MA45526A (fr) * 2016-06-30 2019-05-08 Novo Nordisk As Systèmes et procédés d'analyse de données d'adhésion au régime d'insuline
EP3479264A1 (en) 2016-06-30 2019-05-08 Novo Nordisk A/S Systems and methods for analysis of insulin regimen adherence data
CN109863560B (zh) 2016-08-25 2023-11-17 诺和诺德股份有限公司 基础胰岛素滴定的起始工具包
WO2018037080A1 (en) * 2016-08-25 2018-03-01 Novo Nordisk A/S Starter kit for basal insulin titration
EP3515535A1 (en) 2016-09-23 2019-07-31 Insulet Corporation Fluid delivery device with sensor
US11195607B2 (en) 2016-11-29 2021-12-07 Novo Nordisk A/S Starter kit for basal rate titration
CA3037432A1 (en) 2016-12-12 2018-06-21 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
EP3568859A1 (en) 2017-01-13 2019-11-20 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US10881792B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP3582830A4 (en) 2017-02-15 2020-12-09 University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures Group SYSTEM AND METHOD FOR BINDING THE BODY MASS INDEX TO A DIFFERENT PATIENT PSYCHOLOGICAL STRESS EFFECT ON GLYCEMIA DYNAMICS IN PATIENTS WITH INSULINE DEPENDENT DIABETES
EP3596783A4 (en) 2017-03-20 2020-12-16 Viasat, Inc. HIGH FREQUENCY SEAL AT AN INTERFACE OF WAVE GUIDE BLOCKS
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
AU2019263490A1 (en) 2018-05-04 2020-11-26 Insulet Corporation Safety constraints for a control algorithm-based drug delivery system
US11147922B2 (en) 2018-07-13 2021-10-19 Iowa State University Research Foundation, Inc. Feedback predictive control approach for processes with time delay in the manipulated variable
US11628251B2 (en) 2018-09-28 2023-04-18 Insulet Corporation Activity mode for artificial pancreas system
US11565039B2 (en) 2018-10-11 2023-01-31 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
CA3146965A1 (en) 2019-07-16 2021-02-21 Beta Bionics, Inc. Blood glucose control system
EP4000075A4 (en) 2019-07-16 2023-10-04 Beta Bionics, Inc. BLOOD GLUCOSE CONTROL SYSTEM
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
DE112020004762T5 (de) * 2019-10-04 2022-08-11 Beta Bionics, Inc. Blutzuckerkontrollsystem
EP4069082B1 (en) 2019-12-06 2024-06-05 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
EP4084687A1 (en) * 2019-12-30 2022-11-09 F. Hoffmann-La Roche AG Computer-implemented diabetes management methods
JP7512395B2 (ja) 2020-01-06 2024-07-08 インスレット コーポレイション 持続する残差に基づく食事および／または運動行為の予測
US20210236726A1 (en) * 2020-02-03 2021-08-05 Insulet Corporation Insulin delivery using actual user insulin delivery amounts to accurately predict quantity and timing of insulin reservoir refills
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
CA3165932A1 (en) 2020-02-14 2021-08-19 Dexcom, Inc. Decision support and treatment administration systems
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
KR102474292B1 (ko) * 2020-03-23 2022-12-06 이오플로우(주) 약액 주입 제어 방법 및 컴퓨터 프로그램
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US12115351B2 (en) 2020-09-30 2024-10-15 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
US11688501B2 (en) 2020-12-07 2023-06-27 Beta Bionics, Inc. Ambulatory medicament pump with safe access control
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
FR3125696A1 (fr) * 2021-07-27 2023-02-03 Pkvitality Gestion des alertes dans un procédé de détection de la concentration d’un analyte contenu dans un fluide corporel d’un individu
EP4409581A1 (en) 2021-09-27 2024-08-07 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
WO2024010827A1 (en) 2022-07-05 2024-01-11 Biolinq Incorporated Sensor assembly of a microneedle array-based continuous analyte monitoring device
WO2024089529A1 (en) 2022-10-28 2024-05-02 Medtronic, Inc. Medical device implantation by perioperative patient evaluation preparation
US12097355B2 (en) 2023-01-06 2024-09-24 Insulet Corporation Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation
WO2024178575A1 (zh) * 2023-02-28 2024-09-06 上海移宇科技有限公司 根据实际血糖值的差值的变化率进行自动检测的方法及闭环人工胰腺

Family Cites Families (384)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US561422A (en) 1896-06-02 Paul minnis
US4055175A (en) 1976-05-07 1977-10-25 Miles Laboratories, Inc. Blood glucose control apparatus
FR2387659A1 (fr) 1977-04-21 1978-11-17 Armines Dispositif de controle et regulation de la glycemie
US4151845A (en) 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
US4403984A (en) 1979-12-28 1983-09-13 Biotek, Inc. System for demand-based adminstration of insulin
US4464170A (en) 1982-09-29 1984-08-07 Miles Laboratories, Inc. Blood glucose control apparatus and method
US4731726A (en) 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
US4981779A (en) 1986-06-26 1991-01-01 Becton, Dickinson And Company Apparatus for monitoring glucose
US5216597A (en) 1987-05-01 1993-06-01 Diva Medical Systems Bv Diabetes therapy management system, apparatus and method
US4850959A (en) 1988-08-02 1989-07-25 Bioresearch, Inc. Bioelectrochemical modulation of biological functions using resonant/non-resonant fields synergistically
US4947845A (en) 1989-01-13 1990-08-14 Pacesetter Infusion, Ltd. Method of maximizing catheter longevity in an implantable medication infusion system
US4911168A (en) 1989-01-13 1990-03-27 Pacesetter Infusion, Ltd. Method of screening and selecting intraperitoneal medication infusion pump candidates
US5101814A (en) 1989-08-11 1992-04-07 Palti Yoram Prof System for monitoring and controlling blood glucose
US5091190A (en) 1989-09-05 1992-02-25 Alza Corporation Delivery system for administration blood-glucose lowering drug
US5251126A (en) 1990-10-29 1993-10-05 Miles Inc. Diabetes data analysis and interpretation method
GB9024771D0 (en) 1990-11-14 1991-01-02 Axis Research Assay
GB9104037D0 (en) 1991-02-26 1991-04-10 Hospital For Sick The Children Process for the phosphorylation of insulin
SE9101381D0 (sv) 1991-05-07 1991-05-07 Tomas Moks Peptide hormone solution
US6186145B1 (en) 1994-05-23 2001-02-13 Health Hero Network, Inc. Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator
US7624028B1 (en) 1992-11-17 2009-11-24 Health Hero Network, Inc. Remote health monitoring and maintenance system
US5956501A (en) 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
WO1994016722A1 (en) 1993-01-25 1994-08-04 The Beth Israel Hospital Association Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties
US5917052A (en) 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
US5614224A (en) 1995-04-20 1997-03-25 Womack; Rick W. Nutritional supplement for diabetics
US5665065A (en) * 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
MY115050A (en) 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
US5821217A (en) 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
US6011984A (en) 1995-11-22 2000-01-04 Minimed Inc. Detection of biological molecules using chemical amplification and optical sensors
EP0910578A2 (en) 1996-01-19 1999-04-28 The Board Of Regents, The University Of Texas System Recombinant expression of proteins from secretory cell lines
US5830180A (en) * 1996-07-17 1998-11-03 Aquarius Medical Corporation Fluid management system for arthroscopic surgery
US8734339B2 (en) 1996-12-16 2014-05-27 Ip Holdings, Inc. Electronic skin patch for real time monitoring of cardiac activity and personal health management
AU718500B2 (en) 1997-01-23 2000-04-13 Sumitomo Pharmaceuticals Company, Limited Remedies for diabetes
US20010002269A1 (en) 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
US6558351B1 (en) 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US7267665B2 (en) 1999-06-03 2007-09-11 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US5929055A (en) 1997-06-23 1999-07-27 The Research Foundation Of State University Of New York Therapeutic method for management of diabetes mellitus
EP1030557A4 (en) 1997-10-02 2002-07-31 Univ California PROTEIN PRODUCTION BY EXPRESSION IN SECRETORIC Glands
CO4970787A1 (es) 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
AU5916298A (en) 1998-01-09 1999-07-26 Amylin Pharmaceuticals, Inc. Amylin agonist pharmaceutical compositions containing insulin
WO1999044496A1 (en) 1998-03-05 1999-09-10 Universal Healthwatch, Inc. Apparatus to non-invasively measure glucose or other constituents in aqueous humor using infra-red spectroscopy
US6024699A (en) 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
CA2328607A1 (en) 1998-04-02 1999-10-14 Kun Liu Antidiabetic agents
WO1999059545A1 (en) 1998-05-19 1999-11-25 Sdg, Inc. Targeted liposomal drug delivery system
US6537806B1 (en) 1998-06-02 2003-03-25 University Of Washington Compositions and methods for treating diabetes
US6554798B1 (en) * 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
CN1324234A (zh) 1998-09-25 2001-11-28 格利科克斯有限公司 果糖胺氧化酶,拮抗剂和抑制剂
US6615081B1 (en) 1998-10-26 2003-09-02 Birinder R. Boveja Apparatus and method for adjunct (add-on) treatment of diabetes by neuromodulation with an external stimulator
JP2002531884A (ja) 1998-11-30 2002-09-24 ノボ ノルディスク アクティーゼルスカブ 複数の動作を含む自己治療においてユーザを支援するための方法及びシステム
US6540672B1 (en) 1998-12-09 2003-04-01 Novo Nordisk A/S Medical system and a method of controlling the system for use by a patient for medical self treatment
US20070293742A1 (en) 1998-11-30 2007-12-20 Novo Nordisk A/S Medical System And A Method Of Controlling The System For Use By A Patient For Medical Self Treatment
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
EP1173482A1 (en) 1999-04-27 2002-01-23 Eli Lilly And Company Insulin crystals for pulmonary administration
US6669663B1 (en) 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
US6890568B2 (en) 1999-05-24 2005-05-10 Grant Pierce Method for management of blood glucose levels
US7806886B2 (en) 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
AU5844300A (en) 1999-06-04 2000-12-28 Indian Council Of Medical Research Eugenia jambolina fruit extracts for treating diabetes
AU5453300A (en) 1999-06-29 2001-01-31 Eli Lilly And Company Insulin crystals for pulmonary administration
EP1214596A1 (en) 1999-09-15 2002-06-19 The Regents Of The University Of California Glucose sensing molecules having selected fluorescent properties
DE19954233A1 (de) 1999-11-11 2001-05-31 Nutricia Nv Diabetikernahrung
US6925393B1 (en) * 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
US6572542B1 (en) 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
RU2283495C2 (ru) 2000-03-29 2006-09-10 Юниверсити Оф Вирджиния Пэйтент Фаундейшн Способ, система и программный продукт для оценки контроля гликемии при диабете
JP4580542B2 (ja) 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
AU2001265022A1 (en) 2000-05-25 2001-12-03 Healthetech, Inc. Physiological monitoring using wrist-mounted device
US6605039B2 (en) 2000-07-24 2003-08-12 Medtronic, Inc. Cell-based biosensors suitable for implantable medical device applications
JP2004505042A (ja) 2000-08-02 2004-02-19 ファーマニュートリエンツ 糖尿病及びグルコース変性の予防及び／または治療のための方法及び組成物
US6365176B1 (en) 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
US6575905B2 (en) 2000-09-22 2003-06-10 Knobbe, Lim & Buckingham Method and apparatus for real-time estimation of physiological parameters
WO2002036139A1 (en) 2000-11-01 2002-05-10 Biovan, Inc. Method for management of blood glucose levels
DE60133667T2 (de) 2000-11-30 2009-06-18 Arkray, Inc. Mit kommentareingabefunktion ausgestattete messvorrichtung
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
EP1296590A2 (en) 2001-02-08 2003-04-02 Inverness Medical Limited A personal condition management system
AU2002251944A1 (en) 2001-02-15 2002-09-04 Medtronic Minimed, Inc. Polymers functionalized with fluorescent boronate motifs
US7041468B2 (en) * 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
CN1516592A (zh) 2001-06-18 2004-07-28 �����Ǽ���&������Դ���޹�˾ 用于预防和/或治疗心血管疾病、关节炎、皮肤癌、糖尿病、经前综合症和透皮转运的磷虾和/或海产提取物
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
JP3775263B2 (ja) 2001-08-10 2006-05-17 ニプロ株式会社 記録媒体およびこの記録媒体を用いた血糖測定システム
IL155682A0 (en) 2001-08-20 2003-11-23 Inverness Medical Ltd Wireless diabetes management devices and methods for using the same
US6691043B2 (en) * 2001-08-28 2004-02-10 Maxi-Med, Llc Bolus calculator
US6740072B2 (en) 2001-09-07 2004-05-25 Medtronic Minimed, Inc. System and method for providing closed loop infusion formulation delivery
MY135783A (en) 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
US6827702B2 (en) 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
KR20030025200A (ko) 2001-09-19 2003-03-28 (주)바이오니아 아밀라제의 활성을 억제할 수 있는 옥수수 추출물, 이를함유하는 비만증 또는 당뇨병 치료 또는 예방용 의약적조성물 및 식품 첨가물 그리고 그들의 제조방법
US7204823B2 (en) 2001-12-19 2007-04-17 Medtronic Minimed, Inc. Medication delivery system and monitor
AU2002346491A1 (en) 2001-12-19 2003-07-09 Eli Lilly And Company Crystalline compositions for controlling blood glucose
WO2003061643A1 (es) 2002-01-25 2003-07-31 Laboratorios Silanes, S.A. De C.V. Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2
US20030199445A1 (en) 2002-02-07 2003-10-23 Knudsen Lotte Bjerre Use of GLP-1 compound for treatment of critically ill patients
US7108680B2 (en) 2002-03-06 2006-09-19 Codman & Shurtleff, Inc. Closed-loop drug delivery system
TW200304372A (en) 2002-03-20 2003-10-01 Kanegafuchi Chemical Ind Compositions for diabetes
GB0206792D0 (en) 2002-03-22 2002-05-01 Leuven K U Res & Dev Normoglycemia
US20050177398A1 (en) 2002-04-25 2005-08-11 Motokazu Watanabe Dosage determination supporting device, injector, and health management supporting system
CA2703698C (en) 2002-04-30 2016-11-22 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
US20060264886A9 (en) 2002-05-06 2006-11-23 Pettis Ronald J Method for altering insulin pharmacokinetics
JP2003319758A (ja) 2002-05-07 2003-11-11 Unitika Ltd Ｄ−グルコース吸収抑制方法及びｄ−グルコース吸収抑制剤
US20040018533A1 (en) 2002-06-04 2004-01-29 Adam Gail Isabel Reid Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
US20050014158A1 (en) 2002-06-27 2005-01-20 Adam Gail Isabel Reid Therapeutic methods for reducing fat deposition and treating associated conditions
EP1532979A4 (en) 2002-06-28 2008-01-16 Kissei Pharmaceutical DRUG COMPOSITION FOR REGULATING GLYCEMIA
EP1382363A1 (en) 2002-07-15 2004-01-21 Novo Nordisk A/S Closed loop system for controlling blood glucose levels
FR2842735B1 (fr) 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
US8571801B2 (en) 2002-08-28 2013-10-29 Atkins Nutritionals, Inc. Methods and systems for determining and controlling glycemic responses
JP2004095048A (ja) 2002-08-30 2004-03-25 Toshiba Corp 不揮発性半導体メモリ
US7404796B2 (en) 2004-03-01 2008-07-29 Becton Dickinson And Company System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
EP1558237A4 (en) 2002-09-27 2007-01-17 Martek Biosciences Corp IMPROVED GLYCEMIC REGULATION IN PREDIABETE AND / OR DIABETES TYPE II USING DOCOSAHEXAENOIC ACID
JP4599296B2 (ja) 2002-10-11 2010-12-15 ベクトン・ディキンソン・アンド・カンパニー 単一針または多針皮内（ｉｄ）送達装置に結合されたフィードバックまたはモデルベースコントローラを使用して患者の体内の物質の濃度の連続長期制御を開始し維持するためのシステムおよび方法
US7137951B2 (en) 2002-10-23 2006-11-21 Joseph Pilarski Method of food and insulin dose management for a diabetic subject
WO2004060387A1 (en) 2002-12-27 2004-07-22 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
EP1610758A4 (en) 2003-03-19 2011-11-02 Harry Hebblewhite METHOD AND SYSTEM FOR DETERMINING INSULIN DOSAGE PLANES AND CARBOHYDRATE / INSULIN RELATIONSHIPS IN DIABETICS
WO2004084820A2 (en) * 2003-03-19 2004-10-07 Harry Hebblewhite Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
US7504118B2 (en) 2003-04-11 2009-03-17 Fhg Corporation Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
JP2005029570A (ja) 2003-06-16 2005-02-03 Tokiwa Shokubutsu Kagaku Kenkyusho:Kk コロソリン酸の製造方法
US20050054818A1 (en) 2003-07-02 2005-03-10 Brader Mark Laurence Crystalline compositions for controlling blood glucose
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US20050187749A1 (en) 2003-10-24 2005-08-25 Judy Singley Method, system, and computer program for performing carbohydrate/insulin calculation based upon food weight
KR100567837B1 (ko) 2003-10-24 2006-04-05 케이제이헬스케어 주식회사 혈당측정이 가능한 이동통신단말기와 결합되는 인슐린펌프와, 인슐린 펌프의 제어정보 전송을 위한 네트워크시스템
US20050096637A1 (en) 2003-10-31 2005-05-05 Medtronic, Inc. Sensing food intake
US20080119421A1 (en) 2003-10-31 2008-05-22 Jack Tuszynski Process for treating a biological organism
AU2004285368A1 (en) 2003-11-04 2005-05-12 Meiji Dairies Corporation Alpha-glucosidase activity inhibitor
SG179415A1 (en) 2003-11-06 2012-04-27 Lifescan Inc Drug delivery pen with event notification means
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
EP1711101A1 (en) 2004-01-15 2006-10-18 Glucon Inc. Wearable glucometer
WO2005081173A1 (en) 2004-02-19 2005-09-01 Edward Henry Mathews Diabetes slide ruler for blood glucose control
CA2547934C (en) 2004-02-19 2013-05-21 Abbott Laboratories Methods of using gamma cyclodextrin to control blood glucose and insulin secretion
WO2005081170A2 (en) 2004-02-19 2005-09-01 Edward Henry Mathews Diabetes management and patient database system via mobile communication device
WO2005081171A2 (en) 2004-02-19 2005-09-01 Edward Henry Mathews Insulin bolus calculator for mobile communication device
WO2005081119A2 (en) 2004-02-19 2005-09-01 Edward Henry Mathews Interactive diabetes education system
US7651845B2 (en) 2004-05-13 2010-01-26 The Regents Of The University Of California Method and apparatus for glucose control and insulin dosing for diabetics
WO2005110222A1 (en) 2004-05-18 2005-11-24 Okto Medical Appliance Co., Ltd. Blood sugar control system and medical treatment method using the same
US20100222259A1 (en) 2004-07-09 2010-09-02 Hidekazu Arai Compositions for enhancing the production of PPAR and/or PPAR-associated factors
WO2006022634A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
WO2006022628A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
WO2006022629A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods of identifying risk of type ii diabetes and treatments thereof
WO2006022619A2 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
WO2006022636A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
WO2006022633A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying a risk of type ii diabetes and treatments thereof
WO2006022638A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
US20060040003A1 (en) 2004-08-10 2006-02-23 Alvin Needleman Dietary supplement for supressing appetite, enhancing and extending satiety, improving glycemic control, and stimulant free
US20070060549A1 (en) 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US20120213886A1 (en) 2004-08-25 2012-08-23 U.S. Dept. Of Veterans Affairs Compositions and Methods to Lower Glycohemoglobin Levels
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US7291107B2 (en) 2004-08-26 2007-11-06 Roche Diagnostics Operations, Inc. Insulin bolus recommendation system
EP1698898A3 (en) 2004-09-21 2006-10-11 Foundation of Biomedical Research of the Academy of Athens Prognostic, diagnostic and therapeutic significance in detecting and using TIN-antigen (Tubulo-Interstitial nephritis antigen) and its segments
US20060078593A1 (en) 2004-09-27 2006-04-13 Strozier Deborah C Nutritional compostions comprising a soluble viscous fiber in a solid crisp matrix
WO2006044556A2 (en) 2004-10-14 2006-04-27 Galileo Pharmaceuticals, Inc. Dual inhibitors of lipoxygenase for treating diabetes
US8117020B2 (en) 2004-12-03 2012-02-14 Roche Diagnostics Operations, Inc. Method to determine the degree and stability of blood glucose control in patients with diabetes mellitus via creation and continuous updating of new statistical indicators
ITMI20050010A1 (it) 2005-01-05 2006-07-06 Aboca S P A Composizioni farmaceutiche nutraceutiche dietetiche nutrizionali a base di fibre vegetali
CA2491763A1 (en) 2005-01-06 2006-07-06 Tassos P. Anastassiades Blood glucose control with n-acylated glucosamines
WO2006079124A2 (en) 2005-01-24 2006-07-27 Edward Henry Mathews Apparatus and method for predicting the effect of ingested foodstuff or exercise on blood sugar level of patient and suggesting a corrective action
US20060173260A1 (en) 2005-01-31 2006-08-03 Gmms Ltd System, device and method for diabetes treatment and monitoring
US7390663B2 (en) 2005-02-23 2008-06-24 Streck, Inc. Process, composition and kit for providing a stable whole blood calibrator/control
US20060188995A1 (en) 2005-02-24 2006-08-24 Ryan Wayne L Process, composition and kit for providing a stable whole blood calibrator/control
KR100750988B1 (ko) 2005-03-18 2007-08-22 주식회사 유니젠 천연물유래 진세노사이드를 포함하는 당뇨 또는혈당조절이상의 예방 또는 치료용 약학 조성물
BRPI0500959A (pt) 2005-03-23 2006-11-21 Unicamp uso farmacológico de inibidor da expressão da proteìna coativador 1 alfa do receptor ativado por proliferador do peroxisoma (pgc-1(alfa)) para o tratamento de diabetes mellitus, resistência à insulina e sìndrome metabólica, seu composto e sua composição farmacêuticos
US20120065482A1 (en) 2005-04-08 2012-03-15 Mark Ries Robinson Determination of blood pump system performance and sample dilution using a property of fluid being transported
US20090054753A1 (en) 2007-08-21 2009-02-26 Mark Ries Robinson Variable Sampling Interval for Blood Analyte Determinations
CN101180073A (zh) 2005-04-27 2008-05-14 贾拉尔·梅萨德克 胰岛素组合
US20060263450A1 (en) 2005-05-17 2006-11-23 Julius Oben Method and composition for reducing body weight and improving control of body lipids
US7509156B2 (en) 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
WO2006130901A1 (en) 2005-06-07 2006-12-14 Bayer Healthcare Ag Control of metabolic abnormalities
US8251904B2 (en) 2005-06-09 2012-08-28 Roche Diagnostics Operations, Inc. Device and method for insulin dosing
US20090239944A1 (en) 2005-06-24 2009-09-24 D Orazio Daniel Novel Use of Organic Compounds
ATE551946T1 (de) 2005-07-29 2012-04-15 Univ Degli Studi Udine Vorrichtung und verfahren zur prävention von hypoglykämie in einem menschlichen patienten mit typ 1 diabetes während körperlicher betätigung
ES2439455T3 (es) 2005-08-01 2014-01-23 Mannkind Corporation Procedimiento de preservar la función de las células productoras de insulina
US20070078314A1 (en) 2005-09-30 2007-04-05 Grounsell Richard L System and method for measuring and predicting insulin dosing rates
US7704226B2 (en) 2005-11-17 2010-04-27 Medtronic Minimed, Inc. External infusion device with programmable capabilities to time-shift basal insulin and method of using the same
WO2007062173A1 (en) 2005-11-22 2007-05-31 Vocollect Healthcare Systems, Inc. Advanced diabetes management system (adms)
US8557274B2 (en) 2005-12-06 2013-10-15 Purdue Research Foundation Slowly digesting starch and fermentable fiber
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
US7824333B2 (en) 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
GB2436873A (en) 2006-04-07 2007-10-10 Univ Cambridge Tech Blood glucose monitoring systems
US20070282186A1 (en) 2006-05-02 2007-12-06 Adrian Gilmore Blood glucose monitor with an integrated data management system
WO2008073140A2 (en) * 2006-05-15 2008-06-19 Empirical Technologies Corporation Wrist plethysmograph
US8548544B2 (en) 2006-06-19 2013-10-01 Dose Safety System, method and article for controlling the dispensing of insulin
CA2655566A1 (en) 2006-06-30 2008-01-10 Healthy Interactions, Inc. System, method, and device for providing health information
KR101080955B1 (ko) 2006-07-14 2011-11-08 포항공과대학교 산학협력단 인슐린 분비를 증가시키고 혈당을 감소시키는 표피성장인자
JP5299900B2 (ja) 2006-07-28 2013-09-25 国立大学法人金沢大学 糖尿病関連肝臓由来分泌タンパク質の２型糖尿病または血管障害の診断または治療への利用
US9056165B2 (en) 2006-09-06 2015-06-16 Medtronic Minimed, Inc. Intelligent therapy recommendation algorithm and method of using the same
US20080172027A1 (en) * 2006-10-17 2008-07-17 Blomquist Michael L Insulin pump having basal rate testing features
US20080172030A1 (en) 2006-10-17 2008-07-17 Blomquist Michael L Insulin pump having aweekly schedule
EP2095282A2 (en) 2006-11-01 2009-09-02 SHER, Philip Michael Device for predicting and managing blood glucose concentration by analyzing the effect of, and controlling, pharmacodynamic insulin unit equivalents
US8721584B2 (en) 2006-11-02 2014-05-13 The University Of North Carolina At Chapel Hill Methods and systems for determining an intravenous insulin infusion rate to correct hyperglycemia of a patient, to maintain euglycemia of a patient, and to prevent hypoglycemia of a patient
US20080306353A1 (en) * 2006-11-03 2008-12-11 Douglas Joel S Calculation device for metabolic control of critically ill and/or diabetic patients
US20080119705A1 (en) 2006-11-17 2008-05-22 Medtronic Minimed, Inc. Systems and Methods for Diabetes Management Using Consumer Electronic Devices
WO2008067245A2 (en) 2006-11-29 2008-06-05 University Of Maryland, Baltimore Determining insulin pump rate for tight glycemic control
US20080139910A1 (en) 2006-12-06 2008-06-12 Metronic Minimed, Inc. Analyte sensor and method of using the same
US20080214919A1 (en) 2006-12-26 2008-09-04 Lifescan, Inc. System and method for implementation of glycemic control protocols
US7946985B2 (en) 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US7734323B2 (en) 2007-01-24 2010-06-08 Smiths Medical Asd, Inc. Correction factor testing using frequent blood glucose input
US20080228056A1 (en) 2007-03-13 2008-09-18 Michael Blomquist Basal rate testing using frequent blood glucose input
US20080234943A1 (en) 2007-03-20 2008-09-25 Pinaki Ray Computer program for diabetes management
WO2008124478A1 (en) 2007-04-04 2008-10-16 Pronia Medical Systems, Llc Systems, methods, and computer program product for improved management of medical procedures for patients on medical protocols
US20080255707A1 (en) 2007-04-10 2008-10-16 Hebblewhite Harry R Method and system for categorizing blood glucose tests at test time in a portable device or later in a downloading program and then analyzing the categories separately
WO2008129532A2 (en) 2007-04-19 2008-10-30 Mor Research Applications Ltd. Device system and method for monitoring and controlling blood analyte levels
US20080300572A1 (en) * 2007-06-01 2008-12-04 Medtronic Minimed, Inc. Wireless monitor for a personal medical device system
US10350354B2 (en) 2007-06-21 2019-07-16 Roche Diagnostics Operations, Inc. Device and method for preventing hypoglicemia
DK2170159T3 (en) 2007-06-29 2016-08-29 Hoffmann La Roche Combination communication devices and medical devices to communicate with a wireless remote medical devices
US20090036753A1 (en) 2007-07-31 2009-02-05 King Allen B Continuous glucose monitoring-directed adjustments in basal insulin rate and insulin bolus dosing formulas
JP2010536806A (ja) 2007-08-21 2010-12-02 エイティピー・マーケティング・アンド・プロモーション・アクチェンゲゼルシャフト 糖尿病患者における血糖値をコントロールするための薬草製剤
US7943163B2 (en) 2007-08-22 2011-05-17 Response Scientific, Inc. Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes
US7998069B2 (en) 2007-09-11 2011-08-16 Roche Diagnostics Operations, Inc. Mask algorithms for health management systems
TWI348910B (en) 2007-10-29 2011-09-21 Univ Taipei Medical Composition for controlling blood glucose and method thereof
RU2467387C2 (ru) * 2007-12-10 2012-11-20 БАЙЕР ХЕЛТКЭА ЭлЭлСи Интерфейс для системы измерения и контроля состояния здоровья
WO2009075925A1 (en) * 2007-12-13 2009-06-18 Shaya Steven A Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose
US9199031B2 (en) 2007-12-26 2015-12-01 Ofer Yodfat Maintaining glycemic control during exercise
US20090177147A1 (en) 2008-01-07 2009-07-09 Michael Blomquist Insulin pump with insulin therapy coaching
US20090238879A1 (en) 2008-01-24 2009-09-24 Northwestern University Delivery scaffolds and related methods of use
US20090214511A1 (en) 2008-02-21 2009-08-27 Trung Hong Tran Digestible compositions of inulin for managing blood glucose levels
US8317699B2 (en) 2008-02-29 2012-11-27 Roche Diagnostics Operations, Inc. Device and method for assessing blood glucose control
US20090240127A1 (en) 2008-03-20 2009-09-24 Lifescan, Inc. Methods of determining pre or post meal time slots or intervals in diabetes management
US20090242399A1 (en) 2008-03-25 2009-10-01 Dexcom, Inc. Analyte sensor
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US20090247982A1 (en) 2008-03-27 2009-10-01 Lifescan Inc. Medical Device Mechanical Pump
US8185412B1 (en) 2008-03-28 2012-05-22 Mahesh Harpale Method and apparatus for chronic care treatment control with custom named-type factors and user estimation error correction
WO2009124111A2 (en) 2008-04-01 2009-10-08 Trustees Of Boston University Glucose sensor employing semiconductor nanoelectronic device
EP2260423B1 (en) 2008-04-04 2018-02-28 Hygieia, Inc. Apparatus for optimizing a patient's insulin dosage regimen
US9220456B2 (en) 2008-04-04 2015-12-29 Hygieia, Inc. Systems, methods and devices for achieving glycemic balance
TWI394580B (zh) 2008-04-28 2013-05-01 Halozyme Inc 超快起作用胰島素組成物
US20100256047A1 (en) 2009-04-03 2010-10-07 Lifescan, Inc. Analyte Measurement and Management Device and Associated Methods
EP2276405A4 (en) 2008-05-12 2013-10-09 Us Dept Veterans Affairs AUTOMATED SYSTEM AND METHOD FOR DIABETES CONTROL
JP5361243B2 (ja) 2008-05-13 2013-12-04 キヤノン株式会社 光断層画像撮像装置
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
WO2009144527A1 (en) 2008-06-26 2009-12-03 Laboratorios Silanes, S.A. De C.V. A new metformin glycinate salt for blood glucose control
IT1396465B1 (it) 2008-07-10 2012-12-14 B G Informatica S R L Metodo per la definizione e la gestione interattiva di un trattamento per il controllo del tasso glicemico nel paziente diabetico e dispositivo integrato che attua tale metodo
JP2012507309A (ja) 2008-07-18 2012-03-29 ライフスキャン・インコーポレイテッド 分析物測定及び管理装置並びに関連した方法
KR100918776B1 (ko) 2009-04-20 2009-09-24 계명대학교 산학협력단 폴리에틸렌 글리콜과 갈레이트 카테킨을 이용한 혈당상승 억제 조성물
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US20100044261A1 (en) 2008-08-20 2010-02-25 Bayer Healthcare Llc Health management supply organizing system and methods
EP2355669A2 (en) 2008-09-23 2011-08-17 Rubicon Research Private Limited Dietary fiber compositions
EP2179661A1 (en) 2008-10-23 2010-04-28 Generale Biscuit Biscuit comprising guar gum in a rod-like form
US8992464B2 (en) 2008-11-11 2015-03-31 Hygieia, Inc. Apparatus and system for diabetes management
US8527208B2 (en) 2008-11-17 2013-09-03 Roche Diagnostics International Ag Prandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof
US20120011125A1 (en) 2008-12-23 2012-01-12 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US20100160740A1 (en) 2008-12-24 2010-06-24 Gary Cohen Use of Patterns in a Therapy Management System
US9330237B2 (en) 2008-12-24 2016-05-03 Medtronic Minimed, Inc. Pattern recognition and filtering in a therapy management system
US20100174553A1 (en) 2008-12-24 2010-07-08 Medtronic Minimed, Inc. Diabetes Therapy Management System
US20100161346A1 (en) 2008-12-24 2010-06-24 Kristen Getschmann Systems and Methods for Providing Bolus Dosage Recommendations
US8198320B2 (en) 2008-12-31 2012-06-12 Taipei Medical University Hypoglycemic activity of osthole
DK2388317T3 (da) 2009-01-07 2017-11-27 Yiyuan (Shenzhen) Biotech Ltd Gen, som koder for en human glucokinasemutant, og anvendelser deraf til behandling eller forebyggelse af sygdom
WO2010083570A1 (en) 2009-01-23 2010-07-29 The University Of Sydney Novel metabolic disease therapy
US20140363794A1 (en) 2009-01-26 2014-12-11 EosHealth, Inc. Diabetic Patients Compliance and Outcomes by Publicizing that Increased Compliance Improves Blood Glucose Control and Outcomes
JP5677322B2 (ja) 2009-02-04 2015-02-25 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 血糖コントロールのための情報を提供するための医療システム及び方法
JP5818691B2 (ja) 2009-02-04 2015-11-18 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 血糖コントロールのための医療デバイス及び方法
CA2750052C (en) 2009-02-04 2017-08-22 Sanofi-Aventis Deutschland Gmbh Medical system and method for providing glycemic control based on glycemic response information
JP5677321B2 (ja) 2009-02-04 2015-02-25 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 血糖コントロール用の情報を提供するための医療デバイス及び方法
WO2010091102A1 (en) 2009-02-04 2010-08-12 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
WO2010097796A1 (en) 2009-02-26 2010-09-02 Mor Research Applications Ltd. Method and system for automatic monitoring of diabetes related treatments
US9446194B2 (en) * 2009-03-27 2016-09-20 Dexcom, Inc. Methods and systems for promoting glucose management
RU2011141531A (ru) 2009-04-14 2013-05-20 Эбботт Лэборетриз Питательные эмульсии с высоким содержанием волокон для контроля глюкозы в крови
WO2010129375A1 (en) 2009-04-28 2010-11-11 Abbott Diabetes Care Inc. Closed loop blood glucose control algorithm analysis
US8597274B2 (en) 2009-05-22 2013-12-03 Abbott Diabetes Care Inc. Usability features for integrated insulin delivery system
WO2010135670A2 (en) 2009-05-22 2010-11-25 Abbott Diabetes Care Inc. Safety layer for integrated insulin delivery system
US8257300B2 (en) 2009-05-22 2012-09-04 Abbott Diabetes Care Inc. Safety features for integrated insulin delivery system
GB2471066A (en) 2009-06-10 2010-12-22 Dna Electronics Ltd A glucagon pump controller
US9687194B2 (en) 2009-06-17 2017-06-27 Medtronic Minimed, Inc. Closed-loop glucose and/or insulin control system
US9218453B2 (en) 2009-06-29 2015-12-22 Roche Diabetes Care, Inc. Blood glucose management and interface systems and methods
US20100331652A1 (en) 2009-06-29 2010-12-30 Roche Diagnostics Operations, Inc. Modular diabetes management systems
CA2766944C (en) 2009-06-30 2019-10-29 Lifescan, Inc. Analyte testing methods and device for calculating basal insulin therapy
EP2455875A3 (en) 2009-06-30 2013-01-16 Lifescan Scotland Limited System and method for diabetes management
CN102018766B (zh) 2009-09-16 2013-03-06 博仲盛景医药技术（北京）有限公司 一种植物提取物、其提取方法和用途及含有这种提取物的组合物
KR101632308B1 (ko) 2009-09-23 2016-06-21 삼성전자주식회사 혈당 관리 정보를 제공하는 방법 및 장치
US20110071464A1 (en) 2009-09-23 2011-03-24 Medtronic Minimed, Inc. Semi-closed loop insulin delivery
JP5657678B2 (ja) 2009-09-29 2015-01-21 ライフスキャン・スコットランド・リミテッドＬｉｆｅＳｃａｎ Ｓｃｏｔｌａｎｄ， Ｌｔｄ． 糖尿病管理のための分析物試験方法及びデバイス
EP2483824B1 (en) * 2009-09-30 2017-08-16 DreaMed Diabetes Ltd Monitoring device for management of insulin delivery
US20110098548A1 (en) 2009-10-22 2011-04-28 Abbott Diabetes Care Inc. Methods for modeling insulin therapy requirements
US20110098637A1 (en) * 2009-10-27 2011-04-28 Medtronic Minimed, Inc. Method and System for Configuring an Insulin Infusion Device
US20110115894A1 (en) 2009-11-19 2011-05-19 Daniel Rogers Burnett Device and method for diagnosis and monitoring of neural, opthalmologic and retinal disorders
US20110124996A1 (en) * 2009-11-20 2011-05-26 Roche Diagnostics Operations, Inc. Diabetes health management systems and methods
US8771251B2 (en) 2009-12-17 2014-07-08 Hospira, Inc. Systems and methods for managing and delivering patient therapy through electronic drug delivery systems
US20130109620A1 (en) 2009-12-18 2013-05-02 Rheoscience A/S Balaglitazone compositions and methods
US8759284B2 (en) 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP2525863B1 (en) 2010-01-20 2018-12-05 Roche Diabetes Care GmbH A method and device for improving glycemic control
WO2011094352A1 (en) 2010-01-27 2011-08-04 Baylor Research Institute In-vivo non-viral gene delivery of human vascular endothelial growth factor following islet transplantation
US8579879B2 (en) 2010-02-19 2013-11-12 Medtronic Minimed, Inc. Closed-loop glucose control startup
US20110213332A1 (en) 2010-03-01 2011-09-01 Koorosh Mozayeny Medication delivery system
US9089292B2 (en) 2010-03-26 2015-07-28 Medtronic Minimed, Inc. Calibration of glucose monitoring sensor and/or insulin delivery system
WO2012161670A2 (en) 2010-04-07 2012-11-29 Incube Labs, Llc Method for treating diabetes and other glucose regulation disorders using stem cells
US20120197358A1 (en) 2010-04-09 2012-08-02 Prescott Marvin A Light Therapy for Treating or Managing Diabetes and Metabolic Syndrome
JP2011237408A (ja) 2010-04-14 2011-11-24 Arkray Inc 生体情報測定装置、生体情報測定装置における照明方法、および生体情報測定方法
US9387279B2 (en) 2010-05-05 2016-07-12 The Governing Council Of The University Of Toronto Implantable-glucose responsive insulin delivery device
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
US10561785B2 (en) 2010-06-22 2020-02-18 Medtronic Minimed, Inc. Method and/or system for closed-loop control of glucose to a treatment range
US8543354B2 (en) 2010-06-23 2013-09-24 Medtronic Minimed, Inc. Glucose sensor signal stability analysis
US20120003339A1 (en) 2010-07-02 2012-01-05 Minacapelli Pompeo Compositions and methods for controlling blood glucose levels
US20120006100A1 (en) 2010-07-06 2012-01-12 Medtronic Minimed, Inc. Method and/or system for determining blood glucose reference sample times
WO2012004773A1 (en) 2010-07-09 2012-01-12 Universite De Geneve New uses of nogo-a inhibitors and related methods
US8870807B2 (en) 2010-07-19 2014-10-28 Surag Mantri Gastro-intestinal compression device
CN103003819A (zh) 2010-07-23 2013-03-27 霍夫曼-拉罗奇有限公司 考虑到身体活动对葡萄糖调节系统的影响的系统和方法
JP5905004B2 (ja) 2010-07-23 2016-04-20 アヴァセン， インコーポレイテッド 熱エネルギーの治療的適用のための方法およびシステム
EP2603133A1 (en) 2010-08-10 2013-06-19 Roche Diagnostics GmbH Method and system for improving glycemic control
US20120100248A1 (en) 2010-08-17 2012-04-26 Abbott Laboratories Nutritional composition comprising cereal beta-glucan and salacia extract
US8206340B2 (en) 2010-08-18 2012-06-26 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
CA2751306A1 (en) 2010-09-03 2012-03-03 John Dupre Methods for controlling blood-glucose levels in insulin-requiring subjects
WO2012047800A1 (en) 2010-10-06 2012-04-12 Abbott Laboratories Methods for increasing muscle glucose uptake and decreasing muscle recovery time using amino acid blend
US8588687B2 (en) 2010-10-15 2013-11-19 Roche Diagnostics Operations, Inc. Coexistence of multiple radios in a medical device
US20130225683A1 (en) 2010-10-27 2013-08-29 Prometic Biosciences Inc. Compounds and Pharmaceutical Compositions for Uses in Diabetes
US8919180B2 (en) 2010-10-28 2014-12-30 Medtronic Minimed, Inc. Determination and application of glucose sensor reliability indicator and/or metric
US8657746B2 (en) 2010-10-28 2014-02-25 Medtronic Minimed, Inc. Glucose sensor signal purity analysis
CA2816314C (en) 2010-10-31 2018-03-06 Trustees Of Boston University Blood glucose control system
US8349612B2 (en) 2010-11-15 2013-01-08 Roche Diagnostics Operations, Inc. Guided structured testing kit
CN103415287A (zh) 2010-11-16 2013-11-27 新泽西医科和牙科大学 以安全的线粒体解偶联化学剂治疗ii型糖尿病和糖尿病相关疾病
US20120295985A1 (en) 2010-11-19 2012-11-22 Miller Guy M Methods for improving blood glucose control
CN102462736B (zh) 2010-11-19 2015-07-15 北京唐安营养保健品有限公司 肉桂水提取物的制备方法
US8329232B2 (en) 2010-11-23 2012-12-11 Beijing Tang-An Nutrition & Healthcare Products Co. Ltd. Process for preparing water extract of cinnamon
EP2647703A4 (en) 2010-12-01 2014-05-14 Kikkoman Corp E. COLI TRANSFORMANT, PROCESS FOR PRODUCTION OF FLAVIN-RELATED GLUCOSE DEHYDROGENASE USING THE SAME, AND FLAVIN-RELATED MUTANT GLYCOSIDE DEHYDROGENASE
ES2396844B1 (es) 2010-12-01 2014-01-27 Universitat Politècnica De Catalunya Sistema y método para la estimación simultánea y no invasiva de la glucosa en la sangre, nivel de glucocorticoides y presión arterial
WO2012073986A1 (ja) 2010-12-02 2012-06-07 キッコーマン株式会社 フラビン結合型グルコースデヒドロゲナーゼ、フラビン結合型グルコースデヒドロゲナーゼの製造方法およびそれに用いる酵母形質転換体
RU2013133994A (ru) 2010-12-21 2015-01-27 Нестек С.А. Способы и композиции, применимые для контроля глюкозы в крови животных
US20120173151A1 (en) 2010-12-29 2012-07-05 Roche Diagnostics Operations, Inc. Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels
WO2012097064A1 (en) 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for controlling blood glucose
MX350611B (es) 2011-01-31 2017-09-11 Cadila Healthcare Ltd Tratamiento para la lipodistrofia.
US10010273B2 (en) 2011-03-10 2018-07-03 Abbott Diabetes Care, Inc. Multi-function analyte monitor device and methods of use
DK2685895T3 (en) 2011-03-17 2019-01-21 Univ Newcastle System for self-monitoring and regulation of blood glucose
MX339374B (es) 2011-04-29 2016-05-13 Inst De Investigación En Química Aplic S A De C V Cocristales ionicos con base en metformina.
US8968377B2 (en) 2011-05-09 2015-03-03 The Invention Science Fund I, Llc Method, device and system for modulating an activity of brown adipose tissue in a vertebrate subject
US8766803B2 (en) 2011-05-13 2014-07-01 Roche Diagnostics Operations, Inc. Dynamic data collection
US8755938B2 (en) 2011-05-13 2014-06-17 Roche Diagnostics Operations, Inc. Systems and methods for handling unacceptable values in structured collection protocols
ES2774491T3 (es) 2011-06-07 2020-07-21 Wisconsin Alumni Res Found Terapia génica con insulina basada en hepatocitos para la diabetes
EP2720713A2 (en) 2011-06-17 2014-04-23 Halozyme, Inc. Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme
CN103889317B (zh) 2011-06-23 2017-12-29 弗吉尼亚大学专利基金会 用于监测和控制糖尿病患者的血糖水平的统一平台
CA2843008A1 (en) 2011-07-26 2013-01-31 Glysens Incorporated Tissue implantable sensor with hermetically sealed housing
US8667293B2 (en) 2011-08-11 2014-03-04 Roche Diagnostics Operations, Inc. Cryptographic data distribution and revocation for handheld medical devices
GB2493712B (en) 2011-08-12 2014-07-02 Gene Onyx Ltd Insulin pump
JP2014524297A (ja) 2011-08-18 2014-09-22 ノボ・ノルデイスク・エー／エス データを取り扱うための手段を有する薬剤送達デバイス
WO2013040712A1 (en) 2011-09-20 2013-03-28 Afexa Life Sciences Inc. Composition comprising ku ding cha and ginseng for managing blood glucose levels
WO2013049381A1 (en) 2011-09-28 2013-04-04 Abbott Diabetes Care Inc. Methods for analyte monitoring management and analyte measurement data management, and articles of manufacture related thereto
US20130085682A1 (en) 2011-10-04 2013-04-04 Roche Diagnostics Operations, Inc. Memory card usage with blood glucose devices
US10155090B2 (en) 2011-10-07 2018-12-18 Novo Nordisk A/S System for determining position of an element in relation to another element using magnetic fields
US20130144283A1 (en) 2011-12-02 2013-06-06 Medtronic Ardian Luxembourg S.A.R.L. Treatment of polycystic ovary syndrome using renal neuromodulation and associated systems and methods
CA2858566A1 (en) 2011-12-09 2013-06-13 Joel R. Ehrenkranz System and methods for monitoring food consumption
TW201333870A (zh) 2011-12-21 2013-08-16 艾登工具股份有限公司 決定病人胰島素療法的系統及方法
US9136939B2 (en) * 2011-12-29 2015-09-15 Roche Diabetes Care, Inc. Graphical user interface pertaining to a bolus calculator residing on a handheld diabetes management device
US20130172688A1 (en) 2011-12-29 2013-07-04 Roche Diagnostics Operations, Inc. Diabetes management application for mobile phone
CN104159570A (zh) 2011-12-29 2014-11-19 陈献 稳定的胰高血糖素纳米乳液
WO2013108262A1 (en) 2012-01-18 2013-07-25 Zota Health Care Ltd Synergistic combination for the treatment of diabetic neuropathy
US10694983B2 (en) 2012-01-19 2020-06-30 Medtronic Minimed, Inc. Method and/or system for assessing a patient's glycemic response
US10692589B2 (en) 2012-01-20 2020-06-23 Martin Mueller-Wolf “Indima apparatus” system, method and computer program product for individualized and collaborative health care
KR101166907B1 (ko) 2012-02-08 2012-07-19 최병철 혈당조절 및 생리활성 작용을 하는 서목태(쥐눈이콩) 엑기스와 그 제조방법
WO2013117233A1 (en) 2012-02-10 2013-08-15 Alere Switzerland Gmbh Assay and method for determining insulin-resistance
ES2421956B1 (es) 2012-03-02 2014-09-29 Moehs Ibérica S.L. Nueva forma cristalina de sulfato de sitagliptina
US9080939B2 (en) 2012-03-06 2015-07-14 National Central University Method of measuring glycosylated protein proportion by AC impedance method
US10342592B2 (en) 2012-03-07 2019-07-09 Medtronic Ardian Luxembourg S.A.R.L. Selective modulation of renal nerves
WO2013134548A2 (en) 2012-03-08 2013-09-12 Medtronic Ardian Luxembourg S.A.R.L. Ovarian neuromodulation and associated systems and methods
US20140337041A1 (en) 2012-03-30 2014-11-13 Joseph Madden Mobile Application for Defining, Sharing and Rewarding Compliance with a Blood Glucose Level Monitoring Regimen
US20130281796A1 (en) 2012-04-20 2013-10-24 Broadmaster Biotech Corp. Biosensor with exercise amount measuring function and remote medical system thereof
WO2013172833A1 (en) 2012-05-16 2013-11-21 Melaleuca, Inc. Dietary supplement compositions
US20130317316A1 (en) 2012-05-25 2013-11-28 City Of Hope Carbohydrate modeling methods, systems, and devices
US20150174209A1 (en) 2012-05-25 2015-06-25 Amylin Pharmaceuticals. Llc Insulin-pramlintide compositions and methods for making and using them
US9150482B2 (en) 2012-06-06 2015-10-06 Development Center For Biotechnology GLP-1 potentiators from hedychium coronarium and their applications
US9536449B2 (en) 2013-05-23 2017-01-03 Medibotics Llc Smart watch and food utensil for monitoring food consumption
US9254099B2 (en) 2013-05-23 2016-02-09 Medibotics Llc Smart watch and food-imaging member for monitoring food consumption
US9861744B2 (en) 2012-06-25 2018-01-09 International Business Machines Corporation Managing blood glucose levels
US20140012510A1 (en) 2012-07-09 2014-01-09 Dexcom, Inc Systems and methods for leveraging smartphone features in continuous glucose monitoring
US8492426B1 (en) 2012-07-12 2013-07-23 Anis Ahmad Use of carvedilol for treatment of diabetes mellitus
US20140024907A1 (en) 2012-07-19 2014-01-23 Lifescan, Inc. Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes
WO2014024201A1 (en) 2012-08-06 2014-02-13 Ramchandran T S Regulate and manage blood glucose levels of a subject by promoting cell metabolism with the application of low frequency (20 khz to 70 khz ) airborne ultrasound waves and a machine to produce the airborne ultrasound waves therefor
AR092077A1 (es) 2012-08-10 2015-03-18 Sanofi Aventis Deutschland Sistema medico
WO2014028607A1 (en) 2012-08-14 2014-02-20 Abbott Laboratories Low glycemic index nutritional compositions for preserving muscle mass and improving body composition in diabetics
US9504411B2 (en) 2012-08-28 2016-11-29 Roche Diabetes Care, Inc. Diabetes manager for glucose testing and continuous glucose monitoring
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US9278200B2 (en) 2012-09-19 2016-03-08 Mackay Memorial Hospital Flow control device, system and method for controlling the flow of body fluid
ITTV20120186A1 (it) 2012-09-28 2014-03-29 Alpinestars Res Srl Calzatura sportiva
EP2727587A1 (en) 2012-10-30 2014-05-07 Pharnext Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
CA2891164C (en) 2012-11-13 2021-02-09 Gordagen Pharmaceuticals Pty Ltd Transmucosal delivery of tocotrienol
JP6345186B2 (ja) 2012-12-17 2018-06-20 エムワイギャラクシー リミテッド カンパニー 肥満および関連疾患の治療剤としてのｂｔリポペプチドの使用
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
US9192509B2 (en) 2013-03-11 2015-11-24 Avacen, Inc. Methods and apparatus for therapeutic application of thermal energy including blood viscosity adjustment
US20140296943A1 (en) 2013-03-14 2014-10-02 Biological Illumination, Llc Method for controlling blood glucose levels and digestion cycles
CA2904121C (en) 2013-03-15 2021-02-23 Becton, Dickinson And Company Smart adapter for infusion devices
WO2014145049A2 (en) 2013-03-15 2014-09-18 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9795737B2 (en) 2013-03-15 2017-10-24 Animas Corporation Method and system for closed-loop control of an artificial pancreas
WO2014149781A1 (en) 2013-03-15 2014-09-25 Cercacor Laboratories, Inc. Cloud-based physiological monitoring system
US9619849B2 (en) * 2013-03-26 2017-04-11 Eric Lee Rock Healthcare delivery system and method
WO2014162549A1 (ja) 2013-04-04 2014-10-09 テルモ株式会社 血糖管理システム
US20140303466A1 (en) 2013-04-06 2014-10-09 Applivate, LLC Computer-Based Monitoring of Blood Glucose Levels
US9237866B2 (en) 2013-04-29 2016-01-19 Birch Narrows Development, LLC Blood glucose management
WO2014187812A1 (en) 2013-05-21 2014-11-27 Novo Nordisk A/S Drug delivery device with means for disabling activation of expelling mechanism
US9529385B2 (en) 2013-05-23 2016-12-27 Medibotics Llc Smart watch and human-to-computer interface for monitoring food consumption
EP3000088A4 (en) 2013-05-23 2018-06-27 Iphenotype LLC Method and system for maintaining or improving wellness
US9056049B2 (en) 2013-05-30 2015-06-16 Chin Yuan Huang Micro-particle comprising a protein extract from sweet potato for extending satiety and controlling blood glucose and lipid levels
CN103432572B (zh) 2013-06-21 2018-09-18 四川大学华西医院 一种恒河猴糖尿病肾病模型的制备方法
US9482635B2 (en) 2013-06-25 2016-11-01 Animas Corporation Glucose-measurement systems and methods presenting icons
US20160038077A1 (en) 2013-06-27 2016-02-11 Inspark Technologies, Inc. Systems, Devices, and/or Methods for Identifying Time Periods of Insufficient Blood Glucose Testing
US9486580B2 (en) * 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9878097B2 (en) * 2015-04-29 2018-01-30 Bigfoot Biomedical, Inc. Operating an infusion pump system

Also Published As

Publication number Publication date
US11490837B2 (en) 2022-11-08
JP6602784B2 (ja) 2019-11-06
US20220248989A1 (en) 2022-08-11
EP3046599A1 (en) 2016-07-27
US20150217053A1 (en) 2015-08-06
US20180122505A1 (en) 2018-05-03
AU2015211352A1 (en) 2016-05-05
US11311213B2 (en) 2022-04-26
EP3046599A4 (en) 2017-08-02
US20240335145A1 (en) 2024-10-10
CA2926761C (en) 2023-02-21
US20170076067A1 (en) 2017-03-16
CA2926761A1 (en) 2015-08-06
US11857314B2 (en) 2024-01-02
US20230087860A1 (en) 2023-03-23
EP3046599B1 (en) 2021-07-21
US9604002B2 (en) 2017-03-28
US20170007761A1 (en) 2017-01-12
EP3926638A1 (en) 2021-12-22
JP2019213866A (ja) 2019-12-19
IL246936A0 (en) 2016-11-02
US20170281098A1 (en) 2017-10-05
US9892235B2 (en) 2018-02-13
US20240041357A1 (en) 2024-02-08
IL246936A (en) 2017-02-28
AU2015211352B2 (en) 2019-04-18
JP2017505695A (ja) 2017-02-23
JP6882383B2 (ja) 2021-06-02
WO2015116371A1 (en) 2015-08-06
US9710611B2 (en) 2017-07-18
US9486580B2 (en) 2016-11-08

Similar Documents

Publication Publication Date Title
HK1222357A1 (zh) 胰島素管理
HK1222349A1 (zh) 胰島素管理
IL286448A (en) auto-injector
IL250390A0 (en) Ambulatory subcutaneous administration
GB2528350B (en) Battery management
GB2512545B (en) Update management
SG11201700384WA (en) Managing parameter sets
HK1247581A1 (zh) 注射器
GB201420140D0 (en) Mobility management
HK1252507A1 (zh) 注射器
HK1259346A1 (zh) 注射器
GB201407198D0 (en) Password management
TWM488998U (en) Syringe
SG11201702458RA (en) Operation management
ZA201509306B (en) Inventory management
HK1256092A1 (zh) 注射器
SG10201501070UA (en) Elevator-group management system
GB201421672D0 (en) Secure document management
SG11201704819WA (en) Syringe
GB201519092D0 (en) Syringes
GB201411608D0 (en) Risk management
GB201515447D0 (en) Syringes
ZA201504704B (en) Property management
GB201421250D0 (en) Insulin monitoring solution
GB201420959D0 (en) Sensor enhanced fencerow management